Description
Buy CJC-1295 No DAC + Ipamorelin Blend 10mg AUS Peptides
Product Information
CJC-1295 (No DAC) + Ipamorelin (50/50 Blend) – Research Grade Peptides
Lyophilised Powder | ≥99% Purity
CJC-1295 (No DAC) + Ipamorelin Blend (50/50 Blend) is a synthetically manufactured research peptide blend supplied as a high-purity lyophilised powder. It is characterised as a combined formulation of a growth hormone–releasing hormone (GHRH) analogue (CJC-1295 No DAC / Modified GRF (1-29)) and a growth hormone secretagogue receptor (GHSR) agonist analogue (Ipamorelin), and is supplied strictly for laboratory and analytical research applications.
Research Context
CJC-1295 (No DAC) + Ipamorelin is currently studied in laboratory environments for its interaction with multiple endocrine signalling pathways involved in growth hormone regulation. This blended formulation is commonly investigated in research settings where combined peptide activity is being studied across complementary mechanisms of growth hormone axis stimulation.
In experimental models, peptides within these classes are studied for their interaction with:
• Growth hormone–releasing hormone (GHRH) receptor signalling pathways
• Growth hormone secretagogue receptor (GHSR-1a) signalling pathways
• Endocrine feedback mechanisms involving growth hormone (GH) and insulin-like growth factor-1 (IGF-1)
In laboratory research settings, CJC-1295 (No DAC) (Modified GRF (1-29)) has been examined for its potential involvement in GHRH-mediated growth hormone secretion signalling and pulsatile GH dynamics. Ipamorelin has been examined for its potential involvement in ghrelin-mimetic signalling at GHSR pathways associated with GH release mechanisms.
Research interest in this blend primarily focuses on understanding:
• GHRH receptor and GHSR pathway pharmacology
• Regulation of growth hormone (GH) secretion dynamics and pulsatility
• Endocrine feedback mechanisms involving IGF-1 signalling
• Multi-pathway stimulation models within GH axis research
Any reference to receptor activity or biological mechanisms is provided strictly for scientific context within research settings.
Technical Specifications
| Specification | Details |
|---|---|
| Peptide Name | CJC-1295 (No DAC) + Ipamorelin Blend |
| Purity | ≥99% (HPLC verified) |
| Appearance | White to off-white lyophilised powder |
| Molecular Formula | Blend (CJC-1295 No DAC: C₁₅₂H₂₅₂N₄₄O₄₂ | Ipamorelin: C₃₈H₄₉N₉O₅) |
| Molecular Weight | Blend (CJC-1295 No DAC: ~3,367.9 g/mol | Ipamorelin: ~711.85 g/mol) |
| Amino Acid Length | CJC-1295 No DAC: 29 amino acids | Ipamorelin: 5 amino acids |
| Sequence Type | Synthetic peptide blend (GHRH analogue + GHSR agonist analogue) |
| Solubility | Soluble in bacteriostatic water and sterile aqueous solutions |
| Stability | Stable in lyophilised form when stored correctly |
| Form | Freeze-dried (lyophilised) powder |
| Grade | Research grade |
Storage & Handling
- Store lyophilised peptide at2–8°C for short-term storage.
- For extended storage, keep at−20°C or below.
- Protect fromlight and moisture.
- Avoidrepeated freeze–thaw cyclesafter reconstitution.
- Use appropriatelaboratory handling procedures.
- Proper storage and handling are essential to maintain peptide integrity and stability for research applications.
Intended Use
This product is supplied strictly for laboratory and scientific research purposes only.
It is:
- Not for human consumption
- Not for animal or veterinary use
- Not a therapeutic good
- Not approved for medical, diagnostic, or clinical applications
Any reference to biological mechanisms or receptor activity is provided solely for scientific context.
Purchasers are responsible for ensuring compliance with all applicable laws and proper laboratory protocols.
Reviews
There are no reviews yet.